BBCE RSU IS has compleated the re-planning of the premises and the renovation of the premises is planned to be completed by March 2021. By the time the documentation are being prepared for the purchase of 3D planning software, computers, and 3D printers.
BBCE RSU is running a project to set up a new Finished Dosage Form Laboratory (FDF) to promote research in pharmaceutical technology and drug delivery. It is planned that the lab will be set up in 2022 and it will gradually expand its research area from oral solid dosage forms to biomaterials as drug delivery systems with focus on active molecule release kinetics and carrier particle stability.
BBCE project´s main objective is to establish a joint Baltic Biomaterials Centre of Excellence for advanced biomaterials development based on the long-term strategic cooperation between AO Research Institute Davos, Switzerland (ARI) and Friedrich-Alexander University of Erlangen-Nuremberg, Germany (FAU) on the one hand and RTU RBIDC, LIOS, RSU and RSU IS on the other hand.